NCT02636192View on ClinicalTrials.gov

Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents

CompletedOBSERVATIONAL
Enrollment

200,000

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

April 7, 2017

Study Completion Date

April 7, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

No Intervention

This is an observational study and participants did not receive any intervention in this study.

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT02636192 - Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents | Biotech Hunter | Biotech Hunter